Intraindividual variability in red blood cell thiopurine methyltransferase activity

被引:14
作者
Giverhaug, T
Klemetsdal, B
Lysaa, R
Aarbakke, J
机构
[1] Department of Pharmacology, Institute of Medical Biology, University of Tromsø
关键词
thiopurine methyltransferase (TPMT); leukaemia; circadian variation; 6-mercaptopurine; red blood cells; variability; azathioprine;
D O I
10.1007/s002280050095
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective. Long-term (13 weeks) and circa dian (24 hours) intraindividual variability in red blood cell (RBC) thiopurine methyltransferase (TPMT) activity in healthy subjects was studied. Methods: RBC TPMT activity was measured radiochemically. Results: The variability in RBC TPMT activity was low and was only slightly higher than the imprecision of the TPMT assay. Mean long-term intraindividual variability in RBC TPMT activity was 6.5% (CV) (n = 46). Mean intraindividual circadian variability in RBC TPMT activity was 6.4% (CV) (n = 18). Conclusions: In contrast to what has been observed in children with acute lymphoblastic leukaemia, the intraindividual variability in RBC TPMT activity in healthy subjects was low. The reported changes in baseline RBC TPMT activity in patients are probably therefore due to drugs, disease, assay variation or other, unidentified factors.
引用
收藏
页码:217 / 220
页数:4
相关论文
共 29 条
[1]   THIOPURINE METHYLTRANSFERASE - STRUCTURE-ACTIVITY-RELATIONSHIPS FOR BENZOIC-ACID INHIBITORS AND THIOPHENOL SUBSTRATES [J].
AMES, MM ;
SELASSIE, CD ;
WOODSON, LC ;
VANLOON, JA ;
HANSCH, C ;
WEINSHILBOUM, RM .
JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (03) :354-358
[2]  
BALIS FM, 1989, AM J PEDIAT HEMATOL, V11, P324
[3]  
CAPDEVILLE R, 1994, EUR J CLIN PHARMACOL, V46, P385
[4]  
CAPDEVILLE R, 1995, EUR J CLIN PHARMACOL, V48, P87
[5]   THE IMPORTANCE OF THIOPURINE METHYLTRANSFERASE ACTIVITY FOR THE USE OF AZATHIOPRINE IN TRANSPLANT RECIPIENTS [J].
CHOCAIR, PR ;
DULEY, JA ;
SIMMONDS, HA ;
CAMERON, JS .
TRANSPLANTATION, 1992, 53 (05) :1051-1056
[6]   ALTERED MERCAPTOPURINE METABOLISM, TOXIC EFFECTS, AND DOSAGE REQUIREMENT IN A THIOPURINE METHYLTRANSFERASE-DEFICIENT CHILD WITH ACUTE LYMPHOCYTIC-LEUKEMIA [J].
EVANS, WE ;
HORNER, M ;
CHU, YQ ;
KALWINSKY, D ;
ROBERTS, WM .
JOURNAL OF PEDIATRICS, 1991, 119 (06) :985-989
[7]  
KLEMETSDAL B, 1995, EUR J CLIN PHARMACOL, V48, P495
[8]   IDENTIFICATION OF FACTORS REGULATING THIOPURINE METHYLTRANSFERASE ACTIVITY IN A NORWEGIAN POPULATION [J].
KLEMETSDAL, B ;
STRAUME, B ;
WIST, E ;
AARBAKKE, J .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 44 (02) :147-152
[9]   GENDER DIFFERENCE IN RED-BLOOD-CELL THIOPURINE METHYLTRANSFERASE ACTIVITY [J].
KLEMETSDAL, B ;
WIST, E ;
AARBAKKE, J .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1993, 53 (07) :747-749
[10]   INTERETHNIC DIFFERENCE IN THIOPURINE METHYLTRANSFERASE ACTIVITY [J].
KLEMETSDAL, B ;
TOLLEFSEN, E ;
LOENNECHEN, T ;
JOHNSEN, K ;
UTSI, E ;
GISHOLT, K ;
WIST, E ;
AARBAKKE, J .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (01) :24-31